Compare

GHK-Cu vs MOTS-c

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.
XRedditFacebook

GHK-Cu

120 community reports

Positive 3% · Neutral 97% · Negative 0%

Most reported benefits

Mood
226
Recovery
226
Energy
1

Most reported side effects

Injection site irritation
222

Dose distribution

Median: 2000+ mcg · Most common: 2000+ mcg

0–25
1
25–50
16
50–100
0
100–200
0
200–400
4
400–600
0
600–1000
1
1000–2000
71
2000+
135

How repeat users are trending

Among repeat reporters, 89% said they felt similar to their last entry, 11% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 46 days · Based on 45 repeat reporters

MOTS-c

111 community reports

Positive 17% · Neutral 2% · Negative 81%

Most reported benefits

Appetite
230
Energy
45
Mood
1
Recovery
1

Most reported side effects

Injection site irritation
191

Dose distribution

Median: 2000+ mcg · Most common: 2000+ mcg

0–25
4
25–50
0
50–100
0
100–200
1
200–400
8
400–600
11
600–1000
8
1000–2000
42
2000+
157

How repeat users are trending

Among repeat reporters, 56% said they felt similar to their last entry, 31% more positive, and 13% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 44 days · Based on 45 repeat reporters